CompletedPhase 2NCT01361464
Tipifarnib in Treating Older Patients With Acute Myeloid Leukemia
Studying Acute erythroid leukemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Cancer Institute (NCI)
- Principal Investigator
- Jeffrey Lancet, MDMoffitt Cancer Center
- Intervention
- Tipifarnib(drug)
- Enrollment
- 21 enrolled
- Eligibility
- 65 years · All sexes
- Timeline
- 2011 – 2014
Study locations (7)
- Moffitt Cancer Center, Tampa, Florida, United States
- Emory University/Winship Cancer Institute, Atlanta, Georgia, United States
- Blood and Marrow Transplant Group of Georgia, Atlanta, Georgia, United States
- Johns Hopkins University/Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, United States
- Memorial Sloan-Kettering Cancer Center, New York, New York, United States
- Weill Medical College of Cornell University, New York, New York, United States
- University of North Carolina, Chapel Hill, North Carolina, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01361464 on ClinicalTrials.govOther trials for Acute erythroid leukemia
Additional recruiting or active studies for the same condition.